Internal Medicine, Cardiovascular Disease · Brooklyn, NY
NPI
1457643306
Since 2011
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5303 8th Ave
Brooklyn, NY, 11220
Phone (312) 933-5621
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
883 services
Medicare patients, 2024
76
Average age 73
Drug cost, 2024
$2.3M
19,834 prescriptions
Company payments, 2025
$903
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Congrong Lin was code 93000 (electrocardiogram), 99 times for 60 patients. In total Congrong Lin billed 883 services in 22 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 99 | 60 | $11.94 | $1,182 |
| 99214 Office E&M - Established | Office | 72 | 44 | $104.44 | $7,520 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 64 | 32 | $95.87 | $6,136 |
| 99213 Office E&M - Established | Office | 46 | 34 | $75.24 | $3,461 |
| 93015 Electrocardiogram | Office | 45 | 39 | $57.44 | $2,585 |
| 93306 Echocardiography (TTE/TEE) | Office | 41 | 38 | $168.55 | $6,911 |
| 78452 Myocardial Perfusion Scan | Office | 34 | 34 | $393.16 | $13K |
| J0280 Injection, aminophyllin, up to 250 mg | Office | 34 | 17 | $5.00 | $170 |
| 99442 Telephone Services | Office | 27 | 24 | $81.82 | $2,209 |
| 99204 Office E&M - New | Office | 19 | 19 | $125.19 | $2,379 |
| 93224 Electrocardiogram | Office | 15 | 15 | $61.86 | $928 |
| 93229 Electrocardiogram | Office | 14 | 13 | $722.38 | $10K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 14 | 14 | $176.51 | $2,471 |
| 93228 Electrocardiogram | Office | 13 | 12 | $21.87 | $284 |
By year: 2022 $82K for 927 services; 2023 $55K for 825 services; 2024 $61K for 883 services.
Medicare prescription drug claims, 2024
In 2024, the drug Congrong Lin prescribed most often to Medicare patients was Metoprolol Succinate, with 4,155 prescriptions and refills. In total Congrong Lin wrote 19,834 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 4,155 | 4,604 | 707 | $27K |
| Atorvastatin Calcium Generic | 1,231 | 1,363 | 221 | $5,950 |
| Nitroglycerin Generic | 1,134 | 1,236 | 565 | $28K |
| Xarelto Rivaroxaban | 919 | 985 | 130 | $534K |
| Clopidogrel Clopidogrel Bisulfate | 825 | 923 | 141 | $3,584 |
| Amlodipine Besylate Generic | 784 | 920 | 126 | $2,982 |
| Flecainide Acetate Generic | 750 | 810 | 118 | $7,791 |
| Eliquis Apixaban | 681 | 699 | 111 | $402K |
| Multaq Dronedarone Hcl | 664 | 740 | 101 | $512K |
| Furosemide Generic | 539 | 596 | 127 | $1,047 |
| Losartan Potassium Generic | 499 | 602 | 96 | $2,306 |
| Propranolol Hcl Generic | 478 | 528 | 92 | $2,188 |
| Amiodarone Hcl Generic | 382 | 424 | 69 | $2,348 |
| Ranolazine Er Ranolazine | 376 | 411 | 57 | $10K |
| Metoprolol Tartrate Generic | 345 | 369 | 58 | $1,170 |
Brand drugs: - claims; generic drugs: 15,944 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Congrong Lin $903 ($903 in general payments such as food, travel and fees) from 8 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $267.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $267 |
| Abbott Laboratories ABT | 1 | $156 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $146 |
| Merck Sharp & Dohme LLC MRK | 6 | $127 |
| Pfizer Inc. PFE | 4 | $82.49 |
| Edwards Lifesciences Corporation EW | 2 | $49.93 |
| GlaxoSmithKline, LLC. GSK | 2 | $41.36 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $32.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.